RIPK3 and colorectal carcinoma: To define whether reduced expression of RIPK3 has any prognosis significance in CRC, we employed the Smith Colorectal dataset in the Oncomine® platform that contains 177 CRC cases (Completed/Censored=73/104) and analyzed the survival of CRC patients with different RIPK3 mRNA level.